DRD2 and neoplasm: As expected, we observed more CD31 and TUNEL co-staining in cabergoline-treated tumours than in vehicle-treated tumours (Fig. 2e, f), suggesting that D2R agonist treatment increases apoptosis of tumour-associated endothelial cells.